We are pleased to announce that the X7 Clinical Clinical Center has received accreditation for the right to conduct clinical trials.
The ceremonial opening of the center will take place on November 15th.
X7 Clinical Research is a modern center specializing in conducting clinical trials of bioequivalence phase I, phase II, phase III and post-marketing research of drugs in all therapeutic areas. The main principle of the center is to conduct clinical research at the highest level of quality that complies with local and international legislation, as well as ensuring the safety of research subjects.
The key activities of the center are research of bioequivalence and phase I, as well as conducting studies of therapeutic equivalence and phase III. The work of the center implies strict adherence to the principles of Good Clinical Practice (GCP). The equipment and infrastructure of the center are fully consistent with international standards for clinical research.
Detailed information you can find on the website of the center.